Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00082485 · ClinicalTrials.gov registry record · Phase 2
Baclofen for the Treatment of Cocaine Dependence - 1
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
NCT00082485 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 160 participants.
The verdict
NCT00082485, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy and safety of baclofen for the treatment of cocaine dependence.
Interventions
- OTHER Placebo
- DRUG Baclofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2004-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00082485
The ClinicalTrials.gov registry entry for NCT00082485 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00082485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00082485 about?
NCT00082485 is a clinical study titled "Baclofen for the Treatment of Cocaine Dependence - 1". The purpose of this study is to assess the efficacy and safety of baclofen for the treatment of cocaine dependence.
What is the current status of trial NCT00082485?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2004-06.
What interventions are being tested in trial NCT00082485?
The interventions under investigation include: Placebo (OTHER), Baclofen (DRUG).
Who is sponsoring clinical trial NCT00082485?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.